相補性決定領域
- 関
- CDR、hypervariable region
WordNet
- the approximate amount of something (usually used prepositionally as in `in the region of' (同)neighborhood
- the extended spatial location of something; "the farming regions of France"; "religions in all parts of the world"; "regions of outer space" (同)part
- a knowledge domain that you are interested in or are communicating about; "it was a limited realm of discourse"; "here we enter the region of opinion"; "the realm of the occult" (同)realm
- a large indefinite location on the surface of the Earth; "penguins inhabit the polar regions"
- a relation between two opposite states or principles that together exhaust the possibilities
- the interrelation of reciprocity whereby one thing supplements or depends on the other; "the complementarity of the sexes"
PrepTutorEJDIC
- (地理的な)『地域』,『地帯』;(特に広大な)地方 / 《複数形で》(宇宙などの)区分,界,属 / (身体の)部分 / (学問などの)分野,領域 / 《複数形で》(都会から離れた)地方
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/08/22 01:26:10」(JST)
[Wiki en表示]
The "upper" part (Fab region) of an antibody. The complementarity determining regions of the heavy chain are shown in red (PDB 1IGT).
Complementarity determining regions (CDRs) are regions within antibodies (also known as immunoglobulins) or T cell receptors where these proteins complement an antigen's shape. Thus, CDRs determine the protein's affinity and specificity for specific antigens. The CDRs are the most variable part of the molecule, and contribute to the diversity of these molecules, allowing the antibody and the T cell receptor to recognize a vast repertoire of antigens.
Contents
- 1 Location and structure
- 2 See also
- 3 References
- 4 External links
|
Location and structure
Sketch of an antibody with the variable domains shown in blue, and the CDRs (which are part of the variable domains) in light blue
In the amino acid sequence of a variable domain of an antigen receptor there are three CDRs (CDR1, CDR2 and CDR3), arranged non-consecutively. Since the antigen receptors are typically composed of two variable domains (on two different polypeptide chains, heavy and light chain), there are six CDRs for each antigen receptor that can collectively come into contact with the antigen. A single antibody molecule has two antigen receptors, wherefore it contains twelve CDRs. Sixty CDRs can be found on a pentameric IgM molecule.
Within the variable domain, CDR1 and CDR2 are found in the variable (V) region of a polypeptide chain, and CDR3 includes some of V, all of diverse (D, heavy chains only) and joint (J), and some of the constant (C) regions.[citation needed] CDR3 is the most variable.
Since most sequence variation associated with immunoglobulins and T cell receptors are found in the CDRs, these regions are sometimes referred to as hypervariable regions.[1] Among these, CDR3 shows the greatest variability as it is encoded by a recombination of the VJ in the case of a light chain region and VDJ in the case of heavy chain regions.
The tertiary structure of an antibody is important to analyze and design new antibodies. The three-dimensional structures of the non-H3 CDRs of antibodies have been clustered and classified by Chothia et al.[2] and more recently by North et al.[3] Homology modeling is a computational method to build tertiary structures from amino-acid sequences. The so-called H3-rules are empirical rules to build models of CDR3.[4]
See also
- Framework region
- Hypervariable region
References
- ^ Abbas AK and Lichtman AH (2003). Cellular and Molecular Immunology (5th ed. ed.). Saunders, Philadelphia. ISBN 0-7216-0008-5.
- ^ Al-Lazikani, B.; Lesk, A. M.; Chothia, C. (1997). "Standard conformations for the canonical structures of immunoglobulins". Journal of Molecular Biology 273 (4): 927–948. doi:10.1006/jmbi.1997.1354. PMID 9367782. edit
- ^ North, B.; Lehmann, A.; Dunbrack Jr, R. L. (2011). "A New Clustering of Antibody CDR Loop Conformations". Journal of Molecular Biology 406 (2): 228–256. doi:10.1016/j.jmb.2010.10.030. PMC 3065967. PMID 21035459. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3065967. edit
- ^ Shirai, H; Kidera, A; Nakamura, H (1999). "H3-rules: identification of CDR-H3 structures in antibodies". FEBS Letters 455 (1-2): 188–97. doi:10.1016/S0014-5793(99)00821-2. PMID 10428499. edit
External links
- Complementarity+determining+regions at the US National Library of Medicine Medical Subject Headings (MeSH)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A Small-molecule Screen Yields Idiotype-specific Blockers of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4.
- Phuan PW, Anderson MO, Tradtrantip L, Zhang H, Tan J, Lam C, Bennett JL, Verkman AS.SourceFrom the Departments of Medicine and Physiology, University of California, San Francisco, California 94143-0521.
- The Journal of biological chemistry.J Biol Chem.2012 Oct 26;287(44):36837-44. doi: 10.1074/jbc.M112.408716. Epub 2012 Sep 18.
- Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system caused by binding of anti-aquaporin-4 (AQP4) autoantibodies (NMO-IgG) to AQP4 on astrocytes. A screen was developed to identify inhibitors of NMO-IgG-dependent, complement-dependent cytotoxicity. Screen
- PMID 22989877
- Biased T Cell Receptor Usage Directed against Human Leukocyte Antigen DQ8-Restricted Gliadin Peptides Is Associated with Celiac Disease.
- Broughton SE, Petersen J, Theodossis A, Scally SW, Loh KL, Thompson A, van Bergen J, Kooy-Winkelaar Y, Henderson KN, Beddoe T, Tye-Din JA, Mannering SI, Purcell AW, McCluskey J, Anderson RP, Koning F, Reid HH, Rossjohn J.SourceThe Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Victoria 3800, Australia.
- Immunity.Immunity.2012 Oct 19;37(4):611-21. doi: 10.1016/j.immuni.2012.07.013. Epub 2012 Oct 11.
- Celiac disease is a human leukocyte antigen (HLA)-DQ2- and/or DQ8-associated T cell-mediated disorder that is induced by dietary gluten. Although it is established how gluten peptides bind HLA-DQ8 and HLA-DQ2, it is unclear how such peptide-HLA complexes are engaged by the T cell receptor (TCR),
- PMID 23063329
Japanese Journal
- 抗体開発のための抗原抗体相互作用解析 (特集 抗体デリバリー : 基礎から臨床まで)
- 津本 浩平
- Drug delivery system : DDS : official journal of the Japan Society of Drug Delivery System 28(5), 412-423, 2013-11
- NAID 40019893929
- 津本 浩平
- Drug Delivery System 28(5), 412-423, 2013
- 抗体はその高い抗原特異性、親和性から、治療薬、診断薬に用いられており、各分野で抗体開発が盛んに行われている。抗体配列遺伝子が手に入れば、我々は、その抗体が持つ機能を認識素子として利用し、さまざまな改変抗体を構築することができるようになっている。しかしながら、抗体がどのように抗原に対して高い特異性・親和性を創出するかについて、構造的に、またエネルギー的に理解されるようになったのはごく最近のことである …
- NAID 130003393810
- Evaluation of the Aggregation States of Monoclonal Antibodies by Diverse and Complementary Methods
- Yoshino Tetsuya,Ishikawa Tomoyoshi,Ishihara Takashi [他],Takeuchi Yoshimi,Yoshikawa Hitomi,Yoshida Hideaki,Yoshida Hitoshi,Wakamatsu Kaori
- Biological and Pharmaceutical Bulletin 34(8), 1273-1278, 2011
- … As anti-DNP1 had a longer complementarity-determining region 3 (CDR3) light chain than anti-DNP2 by 2 amino acid residues, we hypothesized that the increased aggregation of DNP1 was due to these extra residues; … The fragment antigen-binding region of this mutant was found to have lower thermal stability than the others by differential scanning calorimetry. …
- NAID 130000936598
Related Links
- 抗体分子のFv上で,実際に抗原に直接接触して結合部位を形成している5〜10残程度の領域を指し,それぞれH鎖とL鎖に3つずつのCDR1,2,3が存在する.一般的にはCDR3が結合における寄与が最も高い.CDRは,抗原に対する特異性を ...
- Define complementarity-determining region (CDR). complementarity-determining region (CDR) synonyms, complementarity-determining region (CDR) pronunciation, complementarity-determining region (CDR) translation, English ...
★リンクテーブル★
[★]
- 英
- humanized antibody, zumab
[★]
- 関
- area、district、division、domain、local、moiety、part、partial、piece、portion、realm、regional、segment、segmental、territory、universe
[★]
- 関
- complementary、complementation